The bone marrow disease myelofibrosis is stimulated by excessive signaling from vitamin D and immune cells known as macrophages, reveals a Japanese research team. These findings could help to develop alternative treatments that do not target problem genes. The team was led by Research Fellow Kanako Wakahashi and Junior Associate Professor Yoshio Katayama (Kobe University Graduate School of Medicine) and the findings were published on February 4 in the online edition of Blood.
There are three types of blood cell: white blood cells, red blood cells, and platelets. All three types are created from hematopoietic stem cells located in the bone marrow. Myelofibrosis causes an abnormal increase in the cells that produce collagen fibers called fibroblasts.
(left column) The bone marrow of wild-type mice is formed of round blood cells.
(right column) The bone marrow of mice with vitamin D receptors knocked out is occupied by spindle-shaped fibroblasts and collagen fibers, shows myelofibrosis. (left column) The bone marrow of wild-type mice is formed of round blood cells.
(right column) The bone marrow of mice with vitamin D receptors knocked out is occupied by spindle-shaped fibroblasts and collagen fibers, shows myelofibrosis.
Credit: Kobe University
Bone marrow of wild-type mice transplanted with JAK2V617F transgenic bone marrow (In the digitized photo the blue part shows fibrosis) (left column) the macrophages remain and the fibers are dyed black with argentation (right) when macrophages are removed the fibrotic parts are barely visible.
Credit: Kobe University
The bone marrow becomes filled with these fibers, preventing the body from producing blood cells as normal. This condition can make it hard to control other diseases, and bone hardening (osteosclerosis) also occurs. Myelofibrosis occurs in blood tumors called myeloproliferative neoplasms, which are caused by genetic mutations of hematopoietic stem cells.
The research team focused on the relationship between blood and bone. Vitamin D is a hormone that regulates calcium, and the team had already shown that vitamin D receptors control the location of hematopoietic cells in the bone marrow.
In this study, the team performed a bone marrow (with vitamin D receptors) transplant for a mouse model without vitamin D receptors (this means it has a high concentration of vitamin D in the body) to create a myelofibrosis model. By analyzing this model, they found that hematopoietic stem cells were strongly stimulated by vitamin D signaling and grew into immune system cells called macrophages.
These pathological macrophages stimulated young osteoblasts (cells that create bone) to induce myelofibrosis and bone hardening (figure 1). The cells known as fibroblasts are thought to be these young osteoblasts. By giving these mice a low vitamin D diet and suppressing the macrophages, the team was able to largely prevent the onset of myelofibrosis.
The team also examined mouse models with the same genetic disorder as myelofibrosis patients (JAK2V61F transgenic mice). These mice presented similar symptoms to myelofibrosis patients, displaying both fibrosis and bone hardening.
They treated the mice by rearing them on a low vitamin D diet, blocking vitamin D receptor signals (removing the vitamin D receptor gene in blood cells) and suppressing macrophages. This proved to be extremely effective in preventing bone marrow fibrosis (figure 2).
The results show that pathological macrophages produced by vitamin D receptor signaling play an important role in the development of myelofibrosis (figure 3). Clinical treatment uses inhibitors to target the causative genes of myeloproliferative tumors, but this is not always effective in treating myelofibrosis.
Professor Katayama comments: "The only permanent cure for this disease is hematopoietic stem cell transplant, but this method is unsuitable for many elderly patients. These new findings may help to develop a treatment method for the elderly targeting the vitamin D pathway and macrophages."
Eleanor Wyllie | EurekAlert!
Combination treatment, diabetes drug and immunotherapy, may help to fight breast cancer
06.02.2019 | University of Helsinki
Study links psoriasis treatment and improvement in heart artery disease
05.02.2019 | NIH/National Heart, Lung and Blood Institute
The so-called Abelian sandpile model has been studied by scientists for more than 30 years to better understand a physical phenomenon called self-organized...
Physicists from the University of Basel have developed a new method to examine the elasticity and binding properties of DNA molecules on a surface at extremely low temperatures. With a combination of cryo-force spectroscopy and computer simulations, they were able to show that DNA molecules behave like a chain of small coil springs. The researchers reported their findings in Nature Communications.
DNA is not only a popular research topic because it contains the blueprint for life – it can also be used to produce tiny components for technical applications.
Since the discovery of the first homoleptic metal carbonyl complex Ni(CO)4 more than 130 years ago, scientists try to obtain further such compounds formed from...
Tumor cells use a certain type of immune cells, the so-called neutrophils, to enhance their ability to form metastases. Scientists have deciphered the mechanisms of this collaboration and found strategies for blocking them. This is reported by researchers from the University of Basel and the University Hospital of Basel in the scientific journal "Nature".
A better understanding of the features that define the interplay between cancer cells and immune cells is key to identifying new cancer therapies. Yet, focus...
A team of physicists headed by Prof. Sebastian Reineke of TU Dresden developed a new method of storing information in fully transparent plastic foils. Their innovative idea was now published in the renowned online journal “Science Advances”.
Prof. Reineke and his LEXOS team work with simple plastic foils with a thickness of less than 50 µm, which is thinner than a human hair. In these transparent...
30.01.2019 | Event News
16.01.2019 | Event News
14.01.2019 | Event News
11.02.2019 | Health and Medicine
11.02.2019 | Information Technology
11.02.2019 | Materials Sciences